JPS6036409B2 - 微生物感染処置用組成物 - Google Patents

微生物感染処置用組成物

Info

Publication number
JPS6036409B2
JPS6036409B2 JP47078240A JP7824072A JPS6036409B2 JP S6036409 B2 JPS6036409 B2 JP S6036409B2 JP 47078240 A JP47078240 A JP 47078240A JP 7824072 A JP7824072 A JP 7824072A JP S6036409 B2 JPS6036409 B2 JP S6036409B2
Authority
JP
Japan
Prior art keywords
dmhp
activity
compounds
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP47078240A
Other languages
English (en)
Japanese (ja)
Other versions
JPS4828610A (US07696358-20100413-C00002.png
Inventor
ジヨゼフ バ−グホ−ル ジエ−ムス
ロバ−ト モリス ブツシユビイ スタンレ−
カレン ロバ−ト
ジヨン ウイリアム ダンクレ− マイクル
フエロ−ン ロバ−ト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS4828610A publication Critical patent/JPS4828610A/ja
Publication of JPS6036409B2 publication Critical patent/JPS6036409B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP47078240A 1971-08-05 1972-08-04 微生物感染処置用組成物 Expired JPS6036409B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3677471 1971-08-05
GB36774/71 1971-08-05
GB3581772A GB1405246A (en) 1971-08-05 1972-08-01 Potentiated antimicrobial compositions
GB35817/72 1972-08-01

Publications (2)

Publication Number Publication Date
JPS4828610A JPS4828610A (US07696358-20100413-C00002.png) 1973-04-16
JPS6036409B2 true JPS6036409B2 (ja) 1985-08-20

Family

ID=26262869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47078240A Expired JPS6036409B2 (ja) 1971-08-05 1972-08-04 微生物感染処置用組成物

Country Status (14)

Country Link
JP (1) JPS6036409B2 (US07696358-20100413-C00002.png)
BE (1) BE787236A (US07696358-20100413-C00002.png)
CS (1) CS172956B2 (US07696358-20100413-C00002.png)
DE (1) DE2238536C2 (US07696358-20100413-C00002.png)
FR (1) FR2150733B1 (US07696358-20100413-C00002.png)
GB (1) GB1405246A (US07696358-20100413-C00002.png)
HU (1) HU170534B (US07696358-20100413-C00002.png)
IE (1) IE36867B1 (US07696358-20100413-C00002.png)
IL (1) IL40050A (US07696358-20100413-C00002.png)
IT (1) IT1057861B (US07696358-20100413-C00002.png)
LU (1) LU65857A1 (US07696358-20100413-C00002.png)
NL (1) NL7210719A (US07696358-20100413-C00002.png)
NO (1) NO139004C (US07696358-20100413-C00002.png)
SE (1) SE434337B (US07696358-20100413-C00002.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63121616U (US07696358-20100413-C00002.png) * 1987-01-30 1988-08-08

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1451043A (en) * 1972-08-01 1976-09-29 Wellcome Found Biologicylly acitve compounds and compositions
GB1454165A (en) * 1972-08-01 1976-10-27 Wellcome Found Biologically active compounds and compositions
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
GB1596044A (en) * 1977-04-14 1981-08-19 Wellcome Found Veterinary compositions
AU572792B2 (en) * 1982-09-20 1988-05-19 Wellcome Foundation Limited, The 2-amino, 4-oxo-pteridine derivatives
CN113897413A (zh) * 2021-10-12 2022-01-07 广州达安基因股份有限公司 一种体外诊断试剂防腐剂及其用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63121616U (US07696358-20100413-C00002.png) * 1987-01-30 1988-08-08

Also Published As

Publication number Publication date
GB1405246A (en) 1975-09-10
DE2238536A1 (de) 1973-02-22
NO139004C (no) 1978-12-20
NO139004B (no) 1978-09-11
IL40050A0 (en) 1972-10-29
NL7210719A (US07696358-20100413-C00002.png) 1973-02-07
SE434337B (sv) 1984-07-23
IT1057861B (it) 1982-03-30
HU170534B (US07696358-20100413-C00002.png) 1977-06-28
FR2150733B1 (US07696358-20100413-C00002.png) 1975-06-20
BE787236A (fr) 1973-02-05
JPS4828610A (US07696358-20100413-C00002.png) 1973-04-16
IE36867B1 (en) 1977-03-16
DE2238536C2 (de) 1984-11-29
LU65857A1 (US07696358-20100413-C00002.png) 1973-02-01
FR2150733A1 (US07696358-20100413-C00002.png) 1973-04-13
IE36867L (en) 1973-02-05
IL40050A (en) 1976-02-29
CS172956B2 (US07696358-20100413-C00002.png) 1977-01-28

Similar Documents

Publication Publication Date Title
CN100379426C (zh) 嘧啶核苷和嘧啶核苷酸前体的制药用途
JP3621102B2 (ja) 新規な酵素阻害剤、その合成及び使用方法
WO1995031987A1 (de) Verwendung von pteridin-derivaten als hemmstoffe der no-synthase
JP2011516478A (ja) 免疫療法のための組成物および方法
US20150299202A1 (en) Heteroaryl alkyne compound and use thereof
US20240122921A1 (en) Methods for cancer therapy
JPS6036409B2 (ja) 微生物感染処置用組成物
KR101458061B1 (ko) 항암용 조성물
CN102218140B (zh) 丹酚酸b和昔布类药物联合用药的抗肿瘤效果
Evans et al. Antileishmanial activity of harmaline and other tryptamine derivatives
US9700547B2 (en) Use of 6-hydroxy-2-pyridones and derivatives thereof for preparing a pharmaceutical composition that acts by inhibiting the human uridine phosphorylase enzyme
EP0443028B1 (en) Non-injection carcinostatic agent for suppressing occurrence of inflammation due to 5-fluorouracil and method for curing cancer
WO2014047782A1 (zh) 含有白藜芦醇及白藜芦醇类衍生物和Bcl-2抑制剂的药物组合物及其应用
WO2018121669A1 (zh) 一种用于治疗癌症的药物组合物及其应用
US4795639A (en) Potentiating formulations
JPS6043097B2 (ja) 飼料利用効率改善剤
US3996356A (en) Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
Shapiro et al. Quantitative Biochemical Differences between Tumor and Host as a Basis for Cancer Chemotherapy: II. Riboflavin
US20220125745A1 (en) Pharmaceutical composition for co-administration of acidosis-inducing drug
US3983238A (en) Substituted pyridinol-containing compositions and methods for the treatment of coccidiosis
US20160113955A1 (en) Compositions And Methods For Immunotherapy
IL44124A (en) Compositions containing 2-amino-4-hydroxy-7,8-dihydro pteridine derivatives for treating microbial infections
US4053602A (en) Compositions for treating coccidiosis containing 5-deazariboflavin and its derivatives
CN108623591A (zh) 一种哌尼诺安化合物的用途
JPH07173055A (ja) 抗コクシジウム組成物